Last reviewed · How we verify

NCT06270459: TRUST

Telerehabilitation Robotics for Upper Limb Rehabilitation After STroke

Recruiting now NA Last updated 11 April 2025
What this trial tests

NA trial testing HMAN Robot in Stroke in 54 participants. Currently enrolling.

Timeline
1 November 2024
Primary endpoint
14 August 2025
14 August 2025

Quick facts

Lead sponsorTan Tock Seng Hospital
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment54
Start date1 November 2024
Primary completion14 August 2025
Estimated completion14 August 2025
Sites1 location across Singapore

Drugs / interventions tested

Conditions studied

Sponsor

Tan Tock Seng Hospital

Who can join

Adults 21 to 90, any sex, with Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

There has been an observed decrease in motor and functional ability and non-use of the impaired limb in chronic patients. This is due to the immediate drop in intensive daily therapy (5 days per week for 3 hours/day) that is usually provided during the inpatient (acute) phase upon discharge from the hospital. In this study, the investigators plan to address the low dosage of therapy in the post-acute discharge phase for stroke survivors.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Telerehabilitation robotics for upper limb rehabilitation after stroke (TRUST): a multi-site pragmatic trial protocol.
    Shankar R, Choo SX, Chen Z, Kuah CWK, et al · · 2026 · PMID 42256580 · DOI 10.3389/fneur.2026.1775829

Verify or expand the search:

Other recruiting trials for Stroke

Currently open trials in the same condition.

Other Tan Tock Seng Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06270459.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing